period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.9,0.29999999999999993,0.0,0.24999999999999994,[0],
1,1.5,0.9,0.6,0.0,0.39999999999999997,[0],The FDA is aware of the emerging drug shortage and is actively monitoring the situation. We encourage manufacturers to report any production challenges and buyers to manage inventories responsibly. Coordination efforts are underway to ensure supply stabilization.
2,1.2,1.0,0.19999999999999996,0.0,0.16666666666666663,[],The FDA is aware of emerging supply challenges in the market. We encourage manufacturers and healthcare providers to report any supply issues and are monitoring the situation closely to ensure patient needs are met.
3,1.1,0.9500000000000001,0.15000000000000002,0.0,0.13636363636363638,[],
4,1.1,0.9500000000000001,0.15000000000000002,0.0,0.13636363636363638,[],The FDA is aware of the emerging drug shortage and is actively monitoring the situation. We encourage manufacturers and healthcare providers to report any supply issues to facilitate timely coordination and resolution.
5,1.5,0.9700000000000001,0.5299999999999999,0.0,0.3533333333333333,[0],The FDA is aware of an emerging shortage in the market. We encourage manufacturers to increase production where possible and urge healthcare providers to report supply issues. Coordination among stakeholders is essential to mitigate impact.
6,1.3,0.9700000000000001,0.32999999999999996,0.0,0.25384615384615383,[],The FDA is aware of an emerging shortage in the market. We encourage manufacturers to report supply capabilities and coordinate efforts to mitigate the impact. Stakeholders are advised to manage inventory responsibly to ensure continued patient access.
7,1.2,0.92,0.2799999999999999,0.0,0.23333333333333328,[],The FDA is closely monitoring the emerging drug shortage situation. We encourage manufacturers and healthcare providers to report any supply disruptions and coordinate efforts to ensure continued patient access.
